Table 2 Associations of various insulin resistance indices with overall, stage I and stage II hypertension

TyG index

2.181 (1.924–2.472)

< 0.001

1.448 (1.256–1.670)

< 0.001

1.432 (1.215–1.688)

< 0.001

TG/HDL-C

1.121 (1.088–1.155)

< 0.001

1.035 (1.008–1.062)

0.01

1.024 (0.995–1.053)

0.10

METS-IR

6.778 (4.917–9.343)

< 0.001

1.769 (1.195–2.619)

0.004

1.553 (1.040–2.321)

0.03

ZJU index

1.023 (1.018–1.029)

< 0.001

1.004 (0.999–1.009)

0.08

1.003 (0.998–1.008)

0.27

Stage I hypertension

TyG index

1.900 (1.654–2.182)

< 0.001

1.286 (1.096–1.510)

0.002

1.292 (1.074–1.554)

0.007

TG/HDL-C

1.010 (1.066–1.136)

< 0.001

1.015 (0.983–1.049)

0.35

1.007 (0.971–1.045)

0.70

METS-IR

5.143 (3.613–7.323)

< 0.001

1.360 (0.873–2.119)

0.17

1.246 (0.789–1.968)

0.34

ZJU index

1.022 (1.016–1.027)

< 0.001

1.002 (0.996–1.007)

0.58

1.001 (0.995–1.007)

0.72

Stage II hypertension

TyG index

3.015 (2.492–3.647)

< 0.001

1.907 (1.530–2.375)

< 0.001

1.834 (1.403–2.397)

< 0.001

TG/HDL-C

1.153 (1.113–1.195)

< 0.001

1.062 (1.027–1.097)

< 0.001

1.038 (1.000–1.078)

0.053

METS-IR

13.159 (8.053–21.502)

< 0.001

3.241 (1.752–5.994)

< 0.001

2.415 (1.275–4.573)

0.007

ZJU index

1.030 (1.023–1.036)

< 0.001

1.008 (1.002–1.014)

0.008

1.005 (0.998–1.011)

0.15